Emerging drugs for acute graft-versus-host disease. - Wikidata - awgldk - TriplyDB

Emerging drugs for acute graft-versus-host disease.

Emerging drugs for acute graft-versus-host disease.

http://www.wikidata.org/entity/Q37515433

about

Cutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic Antigens.

P2860

Q28592282-C6E37D07-B571-4673-A515-BF70847990B8 Q35613336-C1048919-8A30-4F21-9382-0E27CF5B1C28

P2860

Emerging drugs for acute graft-versus-host disease.

http://www.wikidata.org/entity/Q37515433

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emerging drugs for acute graft-versus-host disease.

@en

Emerging drugs for acute graft-versus-host disease.

@nl

type

label

Emerging drugs for acute graft-versus-host disease.

@en

Emerging drugs for acute graft-versus-host disease.

@nl

prefLabel

Emerging drugs for acute graft-versus-host disease.

@en

Emerging drugs for acute graft-versus-host disease.

@nl

P1433

Q37515433-FB6E1F21-C529-4CF4-9D1F-9C5A6DF3BDDD

P1476

Q37515433-BED498EF-6404-48AB-8059-466DD5D5FF64

P2093

Q37515433-50EE6B3A-352F-4705-B625-C8665FDC50A9

Q37515433-5B02AD96-E850-460E-85C4-60D81EE3084E

Q37515433-DE2FFE11-57A0-44F8-9166-842703B4693E

P2860

Q37515433-14984A14-368C-4AE5-8657-C499D644917C

Q37515433-14A9C848-BE03-4DA1-8CD2-1DC9E6925F9C

Q37515433-1E95ECEE-C362-42A0-9013-24FABBD5CBEF

Q37515433-25E4763B-8E3F-4F9F-82A6-A356F378EC2E

Q37515433-2D1E611A-3402-4BAB-98C5-2BC75E69CABC

Q37515433-2D6A9EAD-B93F-4CFB-9217-9048651073C8

Q37515433-31255BCC-76D6-41E6-857A-B87172C1D877

Q37515433-328020AC-E6DB-4F7D-9D63-5F9666109DBC

Q37515433-34023705-4430-478F-AD11-148B01B0B11F

Q37515433-3EC894F3-3275-4C43-8928-F7D6C6E87229

P304

Q37515433-26050AE0-02D0-426B-B985-9E797ED64A28

P31

Q37515433-D3FA7600-8E71-4C63-B210-B24BCAE5C7A8

P356

Q37515433-01E2E2FC-5E2C-4EE2-AE5F-2AD9E39DD904

P407

Q37515433-1C538554-51B9-44F3-9FFE-356506BBA46B

P433

Q37515433-51EF2AFB-E694-4570-948A-DA577D5820F8

P478

Q37515433-9364060F-5E63-4D45-8373-519F9BE81D82

P577

Q37515433-9DBB26F5-68EE-4A80-BB8F-E907426707AB

P698

Q37515433-7AB5F2A1-1D70-45AF-97D0-0392E02174EE

P356

14728210903018891

P1433

Expert Opinion on Emerging Drugs

P1476

Emerging drugs for acute graft-versus-host disease.

@en

P2093

Oleg Krijanovski

http://www.w3.org/2001/XMLSchema#string

Pavan Reddy

http://www.w3.org/2001/XMLSchema#string

Yasser Khaled

http://www.w3.org/2001/XMLSchema#string

P2860

Multilineage potential of adult human mesenchymal stem cells

Pentostatin in steroid-refractory acute graft-versus-host disease

Host-reactive CD8+ memory stem cells in graft-versus-host disease

Toll-like receptor control of the adaptive immune responses

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Pluripotency of mesenchymal stem cells derived from adult marrow

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Leukocyte migration and graft-versus-host disease.

Role of adhesion molecules in activation signaling in T lymphocytes.

Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings.

P304

219-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728210903018891

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19519285

http://www.w3.org/2001/XMLSchema#string